The global biopsy devices market is set to witness a growth rate of 7% in the next 5 years. Rising incidence of cancer; increasing preference for minimally invasive procedures; improved reimbursement scenario; and rising awareness and government initiatives are some of the key factors driving the biopsy devices market.
Biopsy devices are medical instruments used to obtain tissue or fluid samples from the body for diagnostic evaluation, particularly to detect diseases such as cancer. They encompass a variety of tools, including core needle biopsy instruments, fine-needle aspiration devices, vacuum-assisted biopsy systems, and liquid biopsy kits. These devices enable precise sample collection from specific organs or tissues, often under image guidance such as ultrasound, CT, or MRI. Designed for minimally invasive procedures, they improve diagnostic accuracy, reduce patient discomfort, and support early disease detection and personalized treatment planning, making them essential in modern healthcare diagnostics.
Discover the more details-Download the PDF brochure :
https://meditechinsights.com/global-biopsy-devices-market/request-sample/
Rising incidence of cancer to propel market demand
The rising incidence of cancer globally is a major driver for the biopsy devices market, as biopsies are crucial for accurate cancer diagnosis and treatment planning. According to the WHO In 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths, and the cancer cases are expected to increase significantly due to aging populations, lifestyle changes, and environmental factors. Early detection is key to improving survival rates, fueling the demand for advanced biopsy techniques such as image-guided and vacuum-assisted biopsies. Additionally, increasing awareness campaigns and government initiatives promoting regular screenings further boost the adoption of biopsy devices, making them essential in addressing the growing cancer burden worldwide.
Increasing preference for minimally invasive procedures is driving the market growth
The increasing preference for minimally invasive procedures is a key driver of the biopsy devices market, as these techniques offer significant benefits such as reduced pain, quicker recovery, and fewer complications compared to traditional surgical methods. Patients and healthcare providers are increasingly opting for minimally invasive options like core needle and vacuum-assisted biopsies, which require smaller incisions and often use image-guidance for precision. These advancements improve patient comfort and diagnostic accuracy, enhancing treatment outcomes. Additionally, the growing adoption of outpatient settings for such procedures further boosts demand, making minimally invasive biopsy devices a vital component in modern diagnostic practices.
Competitive Analysis
The global biopsy devices market is marked by the presence of established and emerging market players such as Becton, Dickinson and Company, Hologic, Inc., Cardinal Health, Olympus Corporation, Boston Scientific Corporation, Fujifilm Corporation, Medtronic, Stryker, Conmed Corporation, and Teleflex Incorporated; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Unlock key findings! Fill out a quick inquiry to access a sample report
https://meditechinsights.com/global-biopsy-devices-market/request-sample/
Market Segmentation
This report by Medi-Tech Insights provides the size of the global biopsy devices market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, technique, application, and end user.
• Market Size & Forecast (2023-2030), By Product, USD Million
o Needle-Based Biopsy Instruments
 Core Needle Biopsy (CNB)
 Fine Needle Aspiration Biopsy (FNAB)
 Vacuum-Assisted Biopsy (VAB)
o Biopsy Guidance Systems
 Ultrasound-Guided Biopsy
 Stereotactic-Guided Biopsy
 MRI-Guided Biopsy
o Biopsy Forceps
 General Biopsy Forceps
 Hot Biopsy Forceps
o Biopsy Needles
 Disposable
 Reusable
o Biopsy Punches
o Biopsy Tables
o Localization Wires
o Liquid Biopsy Kits
o Others
• Market Size & Forecast (2023-2030), By Technique, USD Million
o Non-Image-Guided Biopsy
o Image-Guided Biopsy
 Ultrasound-Guided Biopsy
 Stereotactic-Guided Biopsy
 MRI-Guided Biopsy
 Other Image-Guided Biopsy Techniques
• Market Size & Forecast (2023-2030), By Application, USD Million
o Colorectal Biopsy
o Prostate Biopsy
o Bone marrow biopsy
o Breast Biopsy
o Lung Biopsy
o Prostate Biopsy
o Liver Biopsy
o Kidney Biopsy
o Others
• Market Size & Forecast (2023-2030), By End User, USD Million
o Hospitals & Breast Care Centres
o Diagnostic Imaging Centres
o Academic & Research Institutes
o Other End Users
o Market Size & Forecast (2023-2030), By Region, USD Million
o North America
 US
 Canada
o Europe
 UK
 Germany
 France
 Italy
 Spain
 Rest of Europe
o Asia Pacific
 China
 India
 Japan
 Rest of Asia Pacific
o Latin America
o Middle East & Africa
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
Top comments (0)